CME

Cme Group Inc. Financials Security & Commodity Brokers, Dealers, Exchanges & Services S&P 500Russell 3000
$303.14Close $217.56 – $315.7152-week range Mid-januaryNext report · estimated

Highlights

Strengths

  • Near its high 4% below its 52-week high

Cautions

  • Trend not confirmed 6 of 8 conditions · 150-day under the 200-day, RS under 70
  • Financial distress Altman Z″ in the distress zone

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Oct 23, 2026
Off 12-month high 4%
1wk down 0.8% price change
1mo up 15.7% price change
12-month return up 20% market up 11% · its own up 10%
F-score — — Not assessed
Altman Z″ 0.59 Elevated risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B — price / book
Earnings yield — EBIT / enterprise value
Cheaper than — of the market · not assessed
Revenue growth up 6% year on year
EPS growth up 15% latest quarter · +13 pts
Sales growth up 13% latest quarter · +12 pts
ROE up 15% return on equity
Free cash margin —
D/E — long-term debt / equity
Net debt / EBITDA —
Interest cover —EBIT / interest

Trade setup

ATR% 2.3% $6.92 a day · 2×ATR $289.30
RS 68 / 99 vs the universe
Trend 6 / 8 150-day under the 200-day, RS under 70
Relative volume 1.0× vs 50-day average
Up/down volume 1.25 50 sessions
Implied move — no scheduled report
Trend template · 6 of 8
  • 150-day average above the 200-day: fails
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

1 flagged
  • Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
Last reported Oct 21, 2026
Results reaction Oct 21, 2026+4% vs market2 sessions after results
Options $4.4M26.1% IV · activity

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $6.5B +6% on FY2024
$0 $10B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $4.9B FY2021 · $4.7B FY2022 · $5.0B FY2023 · $5.6B FY2024 · $6.1B FY2025 · $6.5B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $4.1B +15% on FY2024
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $2.1B FY2021 · $2.6B FY2022 · $2.7B FY2023 · $3.2B FY2024 · $3.5B FY2025 · $4.1B
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Net 62%
0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Net 43% FY2021 · Net 56% FY2022 · Net 54% FY2023 · Net 58% FY2024 · Net 58% FY2025 · Net 62%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $1.6B FY2021 · Cash $2.8B FY2022 · Cash $2.7B FY2023 · Cash $2.9B FY2024 · Cash $2.9B FY2025 · Cash $4.4B
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $4.9B $4.7B $5.0B $5.6B $6.1B $6.5B
Operating income $2.6B $2.6B $3.0B $3.4B $3.9B $4.2B
Net income $2.1B $2.6B $2.7B $3.2B $3.5B $4.1B
Net margin 43% 56% 54% 58% 58% 62%
Earnings per share $5.87 $7.35 $7.49 $8.97 $9.80 $11.30
Cash $1.6B $2.8B $2.7B $2.9B $2.9B $4.4B
Shareholders' equity $26.4B $27.4B $26.9B $26.7B $26.5B $28.7B

What options price now

Expected 1-month range The at-the-money straddle for the expiry nearest a month out, as a share of the price: the move, either way, the option market is pricing by then. The range is the price plus and minus that move; the stock ends inside it a little more often than not. Methodology
$286 – $320 ±5.6% by Nov 27, 2026
Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
About the same 26.1% priced · 27.8% recent
Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
About the same
Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
past week: no change
Positioning
Premium traded
$4.4M calls $3.1M · puts $1.3M · latest session
Puts against calls, by premium Money spent on puts divided by money spent on calls. Measured in dollars rather than contracts on purpose: counting contracts treats a hundred cheap lottery tickets as more meaningful than one large position, which is backwards. Methodology
0.43× -0.00 over the week
Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
calls +748 · puts -1.78k past week

For options traders: ATM IV 26.1% (+1.1% 1w) · 1m ÷ 3m IV 1.02 · 25Δ skew 1.3 pts · Net GEX $10.0M

Most traded contracts

No contract passed the liquidity filters this week.

Filings

SEC EDGAR
FiledReportPeriod to Lag
Oct 23, 2026 Quarterly ↗ Sep 30, 2026 23d
Jul 24, 2026 Quarterly ↗ Jun 30, 2026 24d
Apr 24, 2026 Quarterly ↗ Mar 31, 2026 24d
Feb 26, 2026 Annual ↗ Dec 31, 2025 57d
Oct 24, 2025 Quarterly ↗ Sep 30, 2025 24d
Jul 25, 2025 Quarterly ↗ Jun 30, 2025 25d
Apr 30, 2025 Quarterly ↗ Mar 31, 2025 30d
Feb 27, 2025 Annual ↗ Dec 31, 2024 58d
Nov 8, 2024 Quarterly ↗ Sep 30, 2024 39d
Aug 5, 2024 Quarterly ↗ Jun 30, 2024 36d
May 1, 2024 Quarterly ↗ Mar 31, 2024 31d
Feb 28, 2024 Annual ↗ Dec 31, 2023 59d

Current reports

FiledDisclosed
Oct 21, 2026 Results ↗
Sep 25, 2026 Charter or bylaws ↗
Sep 9, 2026 Director or officer change ↗
Aug 11, 2026 Regulation FD ↗
Jul 22, 2026 Results ↗
Jun 17, 2026 Director or officer change · Regulation FD ↗
Jun 10, 2026 Shareholder vote ↗
May 19, 2026 Shareholder vote ↗
Apr 27, 2026 Material agreement ↗
Apr 22, 2026 Results ↗
Feb 4, 2026 Results ↗
Feb 2, 2026 Regulation FD ↗